Share This Page
Drug Price Trends for NDC 42291-0823
✉ Email this page to a colleague
Average Pharmacy Cost for 42291-0823
| Drug Name | NDC | Price/Unit ($) | Unit | Date |
|---|---|---|---|---|
| >Drug Name | >NDC | >Price/Unit ($) | >Unit | >Date |
Best Wholesale Price for NDC 42291-0823
| Drug Name | Vendor | NDC | Count | Price ($) | Price/Unit ($) | Dates | Price Type |
|---|---|---|---|---|---|---|---|
| TERAZOSIN HCL 10MG CAP | AvKare, LLC | 42291-0823-10 | 1000 | 167.58 | 0.16758 | 2023-06-15 - 2028-06-14 | FSS |
| TERAZOSIN HCL 10MG CAP | AvKare, LLC | 42291-0823-10 | 1000 | 97.52 | 0.09752 | 2023-06-22 - 2028-06-14 | FSS |
| >Drug Name | >Vendor | >NDC | >Count | >Price ($) | >Price/Unit ($) | >Dates | >Price Type |
42291-0823 Market Analysis and Financial Projection
Market Analysis and Price Projections for the Drug NDC: 42291-0823
Understanding the National Drug Code (NDC)
To analyze the market and price projections for a specific drug identified by its NDC number (42291-0823), it is essential to understand what the NDC represents. The National Drug Code (NDC) is a unique, three-segment number used by the FDA to identify drug products. This code is comprised of the labeler code, the product code, and the package code, and it is listed in the FDA's National Drug Code Directory, which contains information on active and certified finished and unfinished drugs[1][5].
Identifying the Drug
The NDC number 42291-0823 can be broken down into its three segments to identify the specific drug product. However, without direct access to the FDA's NDC Directory at this moment, we can only infer general trends and factors that influence drug pricing.
Factors Influencing Drug Pricing
Regulatory Environment
Drug pricing is significantly influenced by regulatory requirements and transparency programs. For example, Oregon's Drug Price Transparency Program mandates that manufacturers report price increases and new high-cost drugs, and health insurers are subject to regulatory oversight. This transparency helps in understanding the factors driving price changes, such as interactions between pharmaceutical supply chain entities, rebates, and discounts[1][2].
Market Competition
Competition from generic drugs and biosimilars is a critical factor in the life sciences industry. Nearly 37% of C-suite executives view competition from these alternatives as a top trend, which can impact pricing strategies and market dynamics. This competition can lead to lower prices for branded drugs as generics and biosimilars enter the market[3].
Patent Expirations
The looming patent cliff, with over $300 billion in sales at risk through 2030 due to expiring patents on high-revenue products, is another significant concern. This can lead to increased competition from generics and biosimilars, potentially affecting the pricing of branded drugs[3].
Price Projections
Overall Market Trends
For the period between January 1, 2025, and December 31, 2025, the Vizient Pharmacy Market Outlook projects a 0.00% overall drug price inflation rate. This suggests a stable pricing environment, but it does not account for individual drug price fluctuations. However, historical data shows that many drugs experience price increases, with an average increase of 15.2% from January 2022 to January 2023, translating to $590 per drug product[2].
Specific Drug Price Projections
Without specific data on the drug associated with NDC 42291-0823, precise price projections are challenging. However:
- Generic and Brand Name Drugs: If the drug is a generic, it might experience price increases similar to those reported in Oregon's transparency program, where the median price increase for generic drugs was 19.9% in 2022. For brand name drugs, the median price increase was 13.4%[2].
- Innovative Therapies: If the drug is part of a new therapeutic class, such as gene therapies or GLP-1 drugs, it may command higher prices due to its innovative nature and the value it brings to patients[3][4].
Case Studies and Examples
Extreme Price Increases
The case of a generic naproxen manufactured by Hikma Pharmaceuticals, which saw a 2,527% price increase from $34.13 in 2012 to $896.44 in 2021, highlights the potential for significant price volatility in the pharmaceutical market. Such extreme increases are rare but illustrate the dynamic nature of drug pricing[1].
Regulatory Impact
Oregon's implementation of an upper payment limit for certain drugs could set a precedent for state-level price controls. This could influence pricing strategies for drugs across different states, potentially leading to more uniform pricing practices[1].
International Price Comparisons
The prices of drugs in the U.S. are significantly higher compared to other countries. In 2022, the average price per unit in the U.S. was 5.5 times as high as in the OECD (excluding the U.S.) and 7.7 times as high as the rest of the world (excluding the U.S.). This disparity is due to both higher prices for the same drugs and a drug mix that skews towards more expensive compounds in the U.S.[4].
Impact of Digital Transformation and Innovation
The life sciences industry is poised for significant transformation in 2025, driven by digital advancements and scientific innovations. The integration of technologies like gen AI and the increased use of data are expected to boost operational efficiencies and drive breakthrough innovations. This could lead to new therapeutic options and potentially higher prices for innovative treatments[3].
Patient Affordability and Access
High prescription drug prices create affordability challenges for patients, healthcare payers, employers, and taxpayers. Increases in drug prices over time have added to these challenges, making it crucial for policymakers and industry leaders to address these issues through transparency programs and regulatory measures[2].
Market Trends by Drug Type
Small Molecule Drugs vs. Biologic Products
Market trends vary significantly between small molecule drugs and biologic products. In the U.S., sales revenues for small molecule drugs grew by 4% in contrast to contractions in other regions. For biologic products, U.S. sales revenues grew by 61%, highlighting the different market dynamics for these drug types[4].
FAQs
What is the National Drug Code (NDC) and how is it used?
The National Drug Code (NDC) is a unique, three-segment number that identifies drug products. It is used by the FDA to track and regulate drugs in the U.S.[1][5].
How do regulatory transparency programs affect drug pricing?
Regulatory transparency programs, like Oregon's, require manufacturers to report price increases and provide detailed information on pricing decisions. This helps in understanding the factors driving price changes and can lead to more informed policy decisions[2].
What impact do generic and biosimilar drugs have on the market?
Generic and biosimilar drugs increase competition, which can lead to lower prices for branded drugs. This competition is a significant trend in the life sciences industry[3].
How do new therapies and innovations influence drug pricing?
New therapies, especially those that are innovative and highly effective, can command higher prices due to their value in treating diseases. However, they also drive the need for sustainable financial models in healthcare[3][4].
What are the key factors influencing drug price projections for 2025?
Key factors include the regulatory environment, market competition from generics and biosimilars, patent expirations, and the impact of new therapies and innovations. Additionally, overall market trends and international price comparisons play significant roles[1][2][3].
Key Takeaways
- Regulatory Environment: Transparency programs and regulatory oversight significantly influence drug pricing.
- Market Competition: Generic and biosimilar drugs drive competition, affecting branded drug prices.
- Patent Expirations: The looming patent cliff will increase competition from generics and biosimilars.
- Innovative Therapies: New and innovative treatments can command higher prices due to their value.
- International Price Disparities: U.S. drug prices are significantly higher than in other countries.
- Digital Transformation: Advances in technology and data use will drive operational efficiencies and innovation.
FAQs
What is the average price increase for prescription drugs in recent years?
From January 2022 to January 2023, the average price increase for prescription drugs was 15.2%, translating to $590 per drug product[2].
How do state-level price controls impact drug pricing?
State-level price controls, such as Oregon's upper payment limit, can set precedents for uniform pricing practices across states, influencing pricing strategies for drugs[1].
What role do biologic products play in the pharmaceutical market?
Biologic products have seen significant growth in sales revenues, especially in the U.S., with a 61% increase, highlighting their importance in the market[4].
How does the FDA's NDC Directory help in tracking drugs?
The FDA's NDC Directory contains information on active and certified finished and unfinished drugs, helping to track and regulate drugs in the U.S.[5].
What are the implications of the patent cliff for the pharmaceutical industry?
The patent cliff, with over $300 billion in sales at risk through 2030, will drive interest in mergers and acquisitions and increase competition from generics and biosimilars, affecting the pricing of branded drugs[3].
Sources
- DrugPatentWatch - Market Analysis and Financial Projection for NDC 42291-0779[1].
- ASPE - Changes in the List Prices of Prescription Drugs, 2017-2023[2].
- Deloitte Insights - 2025 Life Sciences Executive Outlook[3].
- ASPE - International Market Size and Prices[4].
- FDA - National Drug Code Directory[5].
More… ↓
